Stay updated on ACE2 Gum on SARS-CoV-2 Viral Load Clinical Trial
Sign up to get notified when there's something new on the ACE2 Gum on SARS-CoV-2 Viral Load Clinical Trial page.

Latest updates to the ACE2 Gum on SARS-CoV-2 Viral Load Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe clinical trial record for the ACE2 chewing gum COVID-19 study is displayed, including its design, eligibility criteria, and planned outcomes. It indicates the study was terminated for administrative reasons before opening, with zero participants enrolled.SummaryDifference38%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces that NIH is transitioning to using “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI), with updates and FAQs available.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the access-denied page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating restricted access to the study record. The content area now presents an access-denied message instead of the study details.SummaryDifference16%

Stay in the know with updates to ACE2 Gum on SARS-CoV-2 Viral Load Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACE2 Gum on SARS-CoV-2 Viral Load Clinical Trial page.